Consonance Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Consonance Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-604,604	Closed	-$63.2M	–	42
2019 Q4	$63.2M	Buy	+604,604	New	+$67.8M	3.86%	11
2018 Q3	–	Sell	-364,300	Closed	-$50.8M	–	32
2018 Q2	$50.8M	Buy	364,300 +91,600	+34%	+$13M	3.28%	13
2018 Q1	$30.7M	Sell	272,700 -402,792	-60%	-$50.6M	2.81%	15
2017 Q4	$89.2M	Buy	675,492 +73,445	+12%	+$8.63M	8.05%	4
2017 Q3	$61.1M	Buy	+602,047	New	+$64.5M	6.76%	8

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Consonance Capital Management's GWPH Position: Q1 2020 in Review

Consonance Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 604,604 shares — an estimated $63.2M sold.

Consonance Capital Management first reported a position in GWPH in Q3 2017 and held it in 5 quarters. The position peaked at $89.2M in Q4 2017. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Consonance Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Consonance Capital Management sold 604,604 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $63.2M.
Consonance Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 5 quarters.
Consonance Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $89.2M in Q4 2017.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Consonance Capital Management's 13F filing for Q1 2020, filed 15 May 2020.